Nobelpharma to use ProBioGen’s AGE1.CR.pIX vaccine production platform
Nobelpharma has signed a license agreement for the use of ProBioGen’s AGE1.CR.pIX vaccine production platform to develop theirlead vaccine.
If you are not happy with the results below please do another search
Nobelpharma has signed a license agreement for the use of ProBioGen’s AGE1.CR.pIX vaccine production platform to develop theirlead vaccine.